Mojca Adlesic

410 total citations
7 papers, 94 citations indexed

About

Mojca Adlesic is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mojca Adlesic has authored 7 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Mojca Adlesic's work include Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Mojca Adlesic is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Mojca Adlesic collaborates with scholars based in Switzerland and Germany. Mojca Adlesic's co-authors include Ian J. Frew, Peter J. Wild, Sabine Harlander, Anne‐Kristine Lundby, Désirée Schönenberger, Robert A. Jacobs, Michal Rajski, Carsten Lundby, Olga Shakhova and Lukas Sommer and has published in prestigious journals such as Nature Communications, Cancer Research and Kidney International.

In The Last Decade

Mojca Adlesic

7 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mojca Adlesic Switzerland	5	74	40	36	13	12	7	94
Chanil Valasarajan Germany	3	68 0.9×	46 1.1×	55 1.5×	8 0.6×	4 0.3×	6	119
Sheng Yu United Kingdom	6	78 1.1×	25 0.6×	17 0.5×	6 0.5×	16 1.3×	9	118
Gilles Udin Switzerland	2	60 0.8×	30 0.8×	16 0.4×	25 1.9×	7 0.6×	5	94
Brian Hanratty United States	6	40 0.5×	19 0.5×	52 1.4×	8 0.6×	7 0.6×	10	89
P. Gajate Borau Spain	2	60 0.8×	61 1.5×	38 1.1×	7 0.5×	4 0.3×	11	104
Xianxin Li China	5	65 0.9×	27 0.7×	22 0.6×	5 0.4×	12 1.0×	5	96
Xingyi Shi United States	4	89 1.2×	66 1.6×	20 0.6×	7 0.5×	9 0.8×	6	122
Binu Porath United States	3	64 0.9×	36 0.9×	60 1.7×	3 0.2×	17 1.4×	3	87
Kahira L. Saez‐Torres United States	4	37 0.5×	22 0.6×	13 0.4×	7 0.5×	5 0.4×	4	81
Deji Ye China	5	109 1.5×	61 1.5×	12 0.3×	4 0.3×	10 0.8×	7	151

Countries citing papers authored by Mojca Adlesic

Since Specialization

Citations

This map shows the geographic impact of Mojca Adlesic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Adlesic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Adlesic more than expected).

Fields of papers citing papers by Mojca Adlesic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Adlesic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Adlesic. The network helps show where Mojca Adlesic may publish in the future.

Co-authorship network of co-authors of Mojca Adlesic

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Adlesic. A scholar is included among the top collaborators of Mojca Adlesic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Adlesic. Mojca Adlesic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Haas, Ludwig, Mojca Adlesic, Francesca Cuomo, et al.. (2024). Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma. Kidney International. 107(4). 666–686. 2 indexed citations

2.

Lagies, Simon, Athina Ganner, Dietmar A. Plattner, et al.. (2023). Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Cells. 12(8). 1102–1102. 9 indexed citations

3.

Hoefflin, Rouven, Sabine Harlander, Behnaz Ahangarian Abhari, et al.. (2021). Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers. 13(19). 4801–4801. 9 indexed citations

4.

Adlesic, Mojca, Thorsten Kaltenbacher, R. Klar, et al.. (2021). Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers. 13(8). 1852–1852. 5 indexed citations

5.

Gonçalves, Ana, Mojca Adlesic, Simone Brandt, et al.. (2017). Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nature Communications. 8(1). 1466–1466. 23 indexed citations

6.

Schönenberger, Désirée, Sabine Harlander, Michal Rajski, et al.. (2016). Formation of Renal Cysts and Tumors in Vhl/Trp53 -Deficient Mice Requires HIF1α and HIF2α. Cancer Research. 76(7). 2025–2036. 44 indexed citations

7.

Adlesic, Mojca, Christian Frei, & Ian J. Frew. (2016). Cdk4 functions in multiple cell types to controlDrosophilaintestinal stem cell proliferation and differentiation. Biology Open. 5(3). 237–251. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact